These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21914224)

  • 1. Methodology and software to detect viral integration site hot-spots.
    Presson AP; Kim N; Xiaofei Y; Chen IS; Kim S
    BMC Bioinformatics; 2011 Sep; 12():367. PubMed ID: 21914224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
    Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S
    Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.
    Wang GP; Berry CC; Malani N; Leboulch P; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Bushman FD
    Blood; 2010 Jun; 115(22):4356-66. PubMed ID: 20228274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curing genetic disease with gene therapy.
    Williams DA
    Trans Am Clin Climatol Assoc; 2014; 125():122-8; discussion 128-9. PubMed ID: 25125725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of inherited immunodeficiencies.
    Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
    Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for inherited immunodeficiency.
    Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
    Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection.
    Biffi A; Bartolomae CC; Cesana D; Cartier N; Aubourg P; Ranzani M; Cesani M; Benedicenti F; Plati T; Rubagotti E; Merella S; Capotondo A; Sgualdino J; Zanetti G; von Kalle C; Schmidt M; Naldini L; Montini E
    Blood; 2011 May; 117(20):5332-9. PubMed ID: 21403130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.
    Deichmann A; Hacein-Bey-Abina S; Schmidt M; Garrigue A; Brugman MH; Hu J; Glimm H; Gyapay G; Prum B; Fraser CC; Fischer N; Schwarzwaelder K; Siegler ML; de Ridder D; Pike-Overzet K; Howe SJ; Thrasher AJ; Wagemaker G; Abel U; Staal FJ; Delabesse E; Villeval JL; Aronow B; Hue C; Prinz C; Wissler M; Klanke C; Weissenbach J; Alexander I; Fischer A; von Kalle C; Cavazzana-Calvo M
    J Clin Invest; 2007 Aug; 117(8):2225-32. PubMed ID: 17671652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems.
    Zhou S; Bonner MA; Wang YD; Rapp S; De Ravin SS; Malech HL; Sorrentino BP
    Hum Gene Ther Methods; 2015 Feb; 26(1):4-12. PubMed ID: 25545666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency.
    De Ravin SS; Liu S; Sweeney CL; Brault J; Whiting-Theobald N; Ma M; Liu T; Choi U; Lee J; O'Brien SA; Quackenbush P; Estwick T; Karra A; Docking E; Kwatemaa N; Guo S; Su L; Sun Z; Zhou S; Puck J; Cowan MJ; Notarangelo LD; Kang E; Malech HL; Wu X
    Nat Commun; 2022 Jun; 13(1):3710. PubMed ID: 35764638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy.
    Deichmann A; Brugman MH; Bartholomae CC; Schwarzwaelder K; Verstegen MM; Howe SJ; Arens A; Ott MG; Hoelzer D; Seger R; Grez M; Hacein-Bey-Abina S; Cavazzana-Calvo M; Fischer A; Paruzynski A; Gabriel R; Glimm H; Abel U; Cattoglio C; Mavilio F; Cassani B; Aiuti A; Dunbar CE; Baum C; Gaspar HB; Thrasher AJ; von Kalle C; Schmidt M; Wagemaker G
    Mol Ther; 2011 Nov; 19(11):2031-9. PubMed ID: 21862999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
    Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
    N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral gene therapy for X-linked chronic granulomatous disease.
    Kohn DB; Booth C; Kang EM; Pai SY; Shaw KL; Santilli G; Armant M; Buckland KF; Choi U; De Ravin SS; Dorsey MJ; Kuo CY; Leon-Rico D; Rivat C; Izotova N; Gilmour K; Snell K; Dip JX; Darwish J; Morris EC; Terrazas D; Wang LD; Bauser CA; Paprotka T; Kuhns DB; Gregg J; Raymond HE; Everett JK; Honnet G; Biasco L; Newburger PE; Bushman FD; Grez M; Gaspar HB; Williams DA; Malech HL; Galy A; Thrasher AJ;
    Nat Med; 2020 Feb; 26(2):200-206. PubMed ID: 31988463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
    Greene MR; Lockey T; Mehta PK; Kim YS; Eldridge PW; Gray JT; Sorrentino BP
    Hum Gene Ther Methods; 2012 Oct; 23(5):297-308. PubMed ID: 23075105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
    Kaufmann KB; Brendel C; Suerth JD; Mueller-Kuller U; Chen-Wichmann L; Schwäble J; Pahujani S; Kunkel H; Schambach A; Baum C; Grez M
    Mol Ther; 2013 Mar; 21(3):648-61. PubMed ID: 23207695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of gene therapy in X-linked severe combined immunodeficiency.
    Rans TS; England R
    Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous injection of a foamy virus vector to correct canine SCID-X1.
    Burtner CR; Beard BC; Kennedy DR; Wohlfahrt ME; Adair JE; Trobridge GD; Scharenberg AM; Torgerson TR; Rawlings DJ; Felsburg PJ; Kiem HP
    Blood; 2014 Jun; 123(23):3578-84. PubMed ID: 24642749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots.
    Moalic Y; Félix H; Takeuchi Y; Jestin A; Blanchard Y
    J Virol; 2009 Feb; 83(4):1920-9. PubMed ID: 19036816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.